BCM
Bayesian Capital Management’s Biogen BIIB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,940
| Closed | -$265K | – | 557 |
|
|
2025
Q1 | $265K | Buy |
+1,940
| New | +$265K | 0.04% | 420 |
|
|
2024
Q2 | – | Sell |
-8,114
| Closed | -$1.75M | – | 747 |
|
|
2024
Q1 | $1.75M | Sell |
8,114
-3,486
| -30% | -$752K | 0.17% | 173 |
|
|
2023
Q4 | $3M | Buy |
+11,600
| New | +$3M | 0.32% | 75 |
|
|
2021
Q3 | – | Sell |
-11,500
| Closed | -$3.98M | – | 390 |
|
|
2021
Q2 | $3.98M | Buy |
+11,500
| New | +$3.98M | 1.04% | 17 |
|
|
2021
Q1 | – | Sell |
-4,200
| Closed | -$1.03M | – | 536 |
|
|
2020
Q4 | $1.03M | Buy |
+4,200
| New | +$1.03M | 0.27% | 100 |
|
|
2020
Q3 | – | Sell |
-25,000
| Closed | -$6.69M | – | 520 |
|
|
2020
Q2 | $6.69M | Buy |
25,000
+14,900
| +148% | +$3.99M | 1.48% | 3 |
|
|
2020
Q1 | $3.2M | Sell |
10,100
-7,700
| -43% | -$2.44M | 0.69% | 9 |
|
|
2019
Q4 | $5.28M | Buy |
17,800
+13,500
| +314% | +$4.01M | 0.9% | 11 |
|
|
2019
Q3 | $1M | Buy |
+4,300
| New | +$1M | 0.19% | 143 |
|
|
2019
Q1 | – | Sell |
-9,009
| Closed | -$2.71M | – | 557 |
|
|
2018
Q4 | $2.71M | Buy |
9,009
+7,700
| +588% | +$2.32M | 0.56% | 30 |
|
|
2018
Q3 | $462K | Buy |
+1,309
| New | +$462K | 0.08% | 353 |
|
|
2017
Q3 | – | Sell |
-4,000
| Closed | -$1.09M | – | 480 |
|
|
2017
Q2 | $1.09M | Sell |
4,000
-1,676
| -30% | -$455K | 0.4% | 63 |
|
|
2017
Q1 | $1.55M | Buy |
5,676
+2,566
| +83% | +$702K | 0.74% | 11 |
|
|
2016
Q4 | $882K | Buy |
3,110
+800
| +35% | +$227K | 0.22% | 162 |
|
|
2016
Q3 | $723K | Buy |
+2,310
| New | +$723K | 0.47% | 59 |
|
|
2016
Q2 | – | Sell |
-1,604
| Closed | -$418K | – | 402 |
|
|
2016
Q1 | $418K | Buy |
1,604
+557
| +53% | +$145K | 0.39% | 73 |
|
|
2015
Q4 | $321K | Buy |
+1,047
| New | +$321K | 0.46% | 83 |
|